Kaido Kurrikoff

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Pharmaceutics

Scientific reports

International journal of molecular sciences

Expert opinion on drug delivery

University of Tartu

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tartu

Estonia

Senior Researcher :: Institute of Technology

Publications

Heleri Heike Härk, Ly Porosk, Lucas R de Mello, Piret Arukuusk, Emerson Rodrigo da Silva, Kaido Kurrikoff
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics 15 (3) (2023)
Heleri Heike Härk, Ly Porosk, Lucas R de Mello, Piret Arukuusk, Emerson Rodrigo da Silva, Kaido Kurrikoff
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics 15 (3) (2023)
Ly Porosk, Heleri Heike Härk, Piret Arukuusk, Uku Haljasorg, Pärt Peterson, Kaido Kurrikoff
The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue. Pharmaceutics 15 (3) (2023)
Ly Porosk, Heleri Heike Härk, Piret Arukuusk, Uku Haljasorg, Pärt Peterson, Kaido Kurrikoff
The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue. Pharmaceutics 15 (3) (2023)
Heleri Heike Härk, Ly Porosk, Lucas R de Mello, Piret Arukuusk, Emerson Rodrigo da Silva, Kaido Kurrikoff
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications. Pharmaceutics 15 (3) (2023)
Ly Porosk, Heleri Heike Härk, Piret Arukuusk, Uku Haljasorg, Pärt Peterson, Kaido Kurrikoff
The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue. Pharmaceutics 15 (3) (2023)
Sara Silva, Kaido Kurrikoff, Ülo Langel, António José Almeida, Nuno Vale
A Second Life for MAP, a Model Amphipathic Peptide. International journal of molecular sciences 23 (15) (2022)
Kaido Kurrikoff, Tambet Teesalu
Editorial on Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides". Pharmaceutics 14 (3) (2022)
Ly Porosk, Jekaterina Nebogatova, Heleri Heike Härk, Birgit Vunk, Piret Arukuusk, Urve Toots, Mart Ustav, Ülo Langel, Kaido Kurrikoff
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293. Pharmaceutics 14 (9) (2022)
Kristina Kiisholts, Kaido Kurrikoff, Piret Arukuusk, Ly Porosk, Maire Peters, Andres Salumets, Ülo Langel
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosis and Cancer In Vitro Models. Pharmaceutics 13 (10) (2021)
Kaido Kurrikoff, Birgit Vunk, Ülo Langel
Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics. Expert opinion on biological therapy 21 (3) (2020)
Kaido Kurrikoff, Ülo Langel
Recent CPP-based applications in medicine. Expert opinion on drug delivery 16 (11) (2019)
Kaido Kurrikoff, Kadi-Liis Veiman, Kadri Künnapuu, Elin Madli Peets, Tõnis Lehto, Ly Pärnaste, Piret Arukuusk, Ülo Langel
Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide. Scientific reports 7 (1) (2017)

Kaido Kurrikoff.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kaido Kurrikoff